SG161258A1 - Methods and compositions for enhancing vascular access - Google Patents

Methods and compositions for enhancing vascular access

Info

Publication number
SG161258A1
SG161258A1 SG201002482-6A SG2010024826A SG161258A1 SG 161258 A1 SG161258 A1 SG 161258A1 SG 2010024826 A SG2010024826 A SG 2010024826A SG 161258 A1 SG161258 A1 SG 161258A1
Authority
SG
Singapore
Prior art keywords
implantable material
cells
methods
present
functional
Prior art date
Application number
SG201002482-6A
Other languages
English (en)
Inventor
Helen Marie Nugent
Elazer Edelman
Anupam Dalal
Steve Bollinger
Scott Epperly
Original Assignee
Pervasis Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2005/043967 external-priority patent/WO2006062909A2/en
Application filed by Pervasis Therapeutics Inc filed Critical Pervasis Therapeutics Inc
Publication of SG161258A1 publication Critical patent/SG161258A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3808—Endothelial cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Botany (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • External Artificial Organs (AREA)
SG201002482-6A 2005-06-21 2006-06-05 Methods and compositions for enhancing vascular access SG161258A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69270805P 2005-06-21 2005-06-21
PCT/US2005/043967 WO2006062909A2 (en) 2004-12-08 2005-12-06 Methods and compositions for enhancing vascular access

Publications (1)

Publication Number Publication Date
SG161258A1 true SG161258A1 (en) 2010-05-27

Family

ID=39892157

Family Applications (2)

Application Number Title Priority Date Filing Date
SG201002482-6A SG161258A1 (en) 2005-06-21 2006-06-05 Methods and compositions for enhancing vascular access
SG2013075387A SG195537A1 (en) 2005-06-21 2006-06-05 Methods and compositions for enhancing vascular access

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2013075387A SG195537A1 (en) 2005-06-21 2006-06-05 Methods and compositions for enhancing vascular access

Country Status (10)

Country Link
US (2) US20090035346A1 (de)
EP (2) EP2361591A3 (de)
JP (2) JP5632580B2 (de)
CN (3) CN101257861B (de)
AU (1) AU2006262682B2 (de)
CA (2) CA2612751A1 (de)
ES (1) ES2541684T3 (de)
IL (2) IL188263A (de)
SG (2) SG161258A1 (de)
WO (1) WO2007001744A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1874919B1 (de) 2005-04-21 2010-06-09 Massachusetts Institute Of Technology Materialien und verfahren zur änderung einer immunreaktion auf exogene und endogene immunogene, einschliesslich genidentischer und nicht-genidentischer zellen, gewebe oder organe
AU2006262682B2 (en) 2005-06-21 2012-07-05 Shire Regenerative Medicine, Inc. Methods and compositions for enhancing vascular access
CA2668621A1 (en) * 2006-11-07 2008-05-15 Pervasis Therapeutics, Inc. Materials and methods for treating and managing angiogenesis-mediated diseases
WO2008057590A2 (en) * 2006-11-07 2008-05-15 Pervasis Therapeutics, Inc. Methods and compositions for modulating tissue modeling
WO2009097218A1 (en) 2008-01-28 2009-08-06 Biomet 3I, Llc Implant surface with increased hydrophilicity
JP6038123B2 (ja) 2011-04-28 2016-12-07 アブラクシス バイオサイエンス， エルエルシー ナノ粒子組成物の脈管内送達およびそれらの使用
CN102763642B (zh) * 2012-08-14 2014-04-02 郑州赛英科干细胞技术有限公司 一种冷冻保护液以及冷冻保存人胎盘羊膜和绒毛膜的方法
CN105407934A (zh) * 2014-05-27 2016-03-16 诺瓦赫普有限公司 经生物工程改造的同种异体瓣膜
GB2536362B (en) * 2015-03-10 2017-03-08 Stent Tek Ltd Surgical system for the percutaneous creation of an arteriovenous fistula (AVF)
US11389622B1 (en) * 2017-11-13 2022-07-19 Simon B. Rayhanabad Patch for providing dialysis
US11918223B2 (en) 2018-02-02 2024-03-05 University Of Louisville Research Foundation, Inc. Sutureless graft anastomotic quick connect system
CN112823030A (zh) * 2018-08-31 2021-05-18 威斯康星校友研究基金会 动脉内皮细胞种植的血管移植物的生成
CN115376392B (zh) * 2022-08-18 2024-04-26 昆明理工大学 主动脉老化对血管生物力学影响的模拟装置及方法

Family Cites Families (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4418691A (en) * 1981-10-26 1983-12-06 Massachusetts Institute Of Technology Method of promoting the regeneration of tissue at a wound
US4787900A (en) * 1982-04-19 1988-11-29 Massachusetts Institute Of Technology Process for forming multilayer bioreplaceable blood vessel prosthesis
US4820626A (en) * 1985-06-06 1989-04-11 Thomas Jefferson University Method of treating a synthetic or naturally occuring surface with microvascular endothelial cells, and the treated surface itself
IL78950A (en) 1985-06-06 1991-12-15 Univ Jefferson Coating for prosthetic devices
US4732155A (en) * 1985-08-27 1988-03-22 The Children's Medical Center Corporation Implantable chemoattractant system
US5863531A (en) * 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
CA1340581C (en) * 1986-11-20 1999-06-08 Joseph P. Vacanti Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
US5736372A (en) * 1986-11-20 1998-04-07 Massachusetts Institute Of Technology Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
US5567612A (en) * 1986-11-20 1996-10-22 Massachusetts Institute Of Technology Genitourinary cell-matrix structure for implantation into a human and a method of making
US5759830A (en) * 1986-11-20 1998-06-02 Massachusetts Institute Of Technology Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo
US6309635B1 (en) * 1986-11-20 2001-10-30 Children's Medical Center Corp. Seeding parenchymal cells into compression resistant porous scaffold after vascularizing in vivo
US5073492A (en) * 1987-01-09 1991-12-17 The Johns Hopkins University Synergistic composition for endothelial cell growth
US5145769A (en) * 1987-08-21 1992-09-08 Cryolife Inc. Method for cryopreserving blood vessels
US5202120A (en) * 1987-09-11 1993-04-13 Case Western Reserve University Methods of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes
US4945086A (en) 1988-05-03 1990-07-31 The Board Of Trustees Of The Leland Stanford Junior University Smooth muscle cell growth inhibitor
US5575815A (en) * 1988-08-24 1996-11-19 Endoluminal Therapeutics, Inc. Local polymeric gel therapy
US5843156A (en) * 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
CH676195A5 (de) * 1988-10-07 1990-12-28 Sulzer Ag
JPH03133901A (ja) * 1989-10-19 1991-06-07 Osaka Gas Co Ltd 生体細胞の凍結保存方法
WO1991007154A1 (en) * 1989-11-13 1991-05-30 President And Fellows Of Harvard College EXTRALUMINAL REGULATION OF THE GROWTH AND REPAIR OF TUBULAR STRUCTURES ιIN VIVO
US5527532A (en) * 1989-11-13 1996-06-18 President And Fellows Of Harvard College Extraluminal regulation of the growth and repair of tubular structures in vivo
US5540928A (en) * 1991-02-27 1996-07-30 President And Fellows Of Harvard College Extraluminal regulation of the growth and repair of tubular structures in vivo
CA2071137A1 (en) * 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
ATE237682T1 (de) 1991-07-15 2003-05-15 Oklahoma Med Res Found Universale spenderzellen
US5336615A (en) 1992-01-06 1994-08-09 Yale University Genetically engineered endothelial cells exhibiting enhanced migration and plasminogen activator activity
JPH0646840A (ja) * 1992-08-04 1994-02-22 Nippon Zenyaku Kogyo Kk 細胞凍結保存液
US5399665A (en) * 1992-11-05 1995-03-21 Massachusetts Institute Of Technology Biodegradable polymers for cell transplantation
US5981568A (en) * 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) * 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
GB9306449D0 (en) * 1993-03-29 1993-05-19 Nat Heart Research Fund Tissue equivalents
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5645829A (en) * 1993-06-18 1997-07-08 Beth Israel Hospital Association Mesothelial cell gene therapy
US6176874B1 (en) * 1993-10-18 2001-01-23 Masschusetts Institute Of Technology Vascularized tissue regeneration matrices formed by solid free form fabrication techniques
US6608182B1 (en) * 1994-03-08 2003-08-19 Human Genome Sciences, Inc. Human vascular endothelial growth factor 2
WO1995029713A1 (en) 1994-04-29 1995-11-09 W.L. Gore & Associates, Inc. Improved blood contact surfaces using endothelium on a subendothelial extracellular matrix
US5834029A (en) * 1994-07-20 1998-11-10 Cytotherapeutics, Inc. Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
US6911216B1 (en) * 1994-10-12 2005-06-28 Genzyme Corporation Targeted delivery via biodegradable polymers
EP0785774B1 (de) * 1994-10-12 2001-01-31 Focal, Inc. Zielgerichte verabreichung mittels biologisch abbaubarer polymere
US5914268A (en) * 1994-11-21 1999-06-22 National Jewish Center For Immunology & Respiratory Medicine Embryonic cell populations and methods to isolate such populations
US5716404A (en) * 1994-12-16 1998-02-10 Massachusetts Institute Of Technology Breast tissue engineering
US6281015B1 (en) * 1994-12-16 2001-08-28 Children's Medical Center Corp. Localized delivery of factors enhancing survival of transplanted cells
US5855610A (en) * 1995-05-19 1999-01-05 Children's Medical Center Corporation Engineering of strong, pliable tissues
US5766584A (en) * 1995-06-02 1998-06-16 Massachusetts Institute Of Technology Inhibition of vascular smooth muscle cell proliferation with implanted matrix containing vascular endothelial cells
US6615071B1 (en) * 1995-09-20 2003-09-02 Board Of Regents, The University Of Texas System Method and apparatus for detecting vulnerable atherosclerotic plaque
US5897987A (en) * 1996-03-25 1999-04-27 Advanced Reproduction Technologies, Inc. Use of arabinogalactan in cell cryopreservation media
US6886568B2 (en) * 1998-04-08 2005-05-03 The Johns Hopkins University Method for fabricating cell-containing implants
JP2002537761A (ja) * 1998-11-24 2002-11-12 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ トランスジェニック循環内皮細胞
US6328762B1 (en) * 1999-04-27 2001-12-11 Sulzer Biologics, Inc. Prosthetic grafts
US6387116B1 (en) * 1999-06-30 2002-05-14 Pharmasonics, Inc. Methods and kits for the inhibition of hyperplasia in vascular fistulas and grafts
US6461631B1 (en) * 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
AU2001243248A1 (en) * 2000-02-23 2001-09-03 Smith Kline Beecham Corporation Method for the prevention or reduction of vascular access dysfunction
AU2001245660B2 (en) * 2000-03-13 2006-06-15 Biocompatibles Uk Limited Embolic compositions
CN100506293C (zh) * 2000-03-15 2009-07-01 祥丰医疗有限公司 促进内皮细胞粘附的涂层
WO2001070021A1 (fr) * 2000-03-24 2001-09-27 Menicon Co., Ltd. Procede de conservation d'equivalent au tissu et equivalent au tissu conserver a l'etat congele
US6506398B1 (en) * 2000-04-28 2003-01-14 Hosheng Tu Device for treating diabetes and methods thereof
WO2001095717A2 (en) * 2000-06-09 2001-12-20 Organ Recovery Systems Cryopreservation method using cryoprotective composition of propanediol and a vehicle solution
AU2001277112A1 (en) 2000-07-21 2002-02-05 Board Of Regents, The University Of Texas System Device providing regulated growth factor delivery for the regeneration of peripheral nerves
US6696483B2 (en) * 2000-10-03 2004-02-24 Oncopharmaceutical, Inc. Inhibitors of angiogenesis and tumor growth for local and systemic administration
JP2002200161A (ja) * 2000-10-24 2002-07-16 Menicon Co Ltd 培養皮膚代替物の製造方法およびそれにより得られる培養皮膚代替物
US6565601B2 (en) * 2000-11-15 2003-05-20 Micro Therapeutics, Inc. Methods for vascular reconstruction of diseased arteries
EP1389078A4 (de) * 2000-12-27 2004-03-17 Ortec International Inc Verfahren zur herstellung kryokonservierter zusammengesetzter lebendkonstrukte und daraus gebildete produkte
BR0206464A (pt) * 2001-01-16 2005-01-18 Vascular Therapies Llc Aparelho e processos para impedir ou tratar insuficiência de acesso vascular para hemodiálise e outros enxertos vasculares
US6723131B2 (en) 2001-02-28 2004-04-20 The Cleveland Clinic Foundation Composite bone marrow graft material with method and kit
AU2002330131A1 (en) 2001-09-28 2003-04-07 Goldberg, Eugene, P. Biopolymer and biopolymer-cell compositions for nerve tissue repair
US7297540B2 (en) * 2002-01-15 2007-11-20 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods of generating tissue using devitalized, acellular scaffold matrices derived from micro-organs
US20040047843A1 (en) * 2002-02-12 2004-03-11 Uab Research Foundation Method for spinal cord reconnection
WO2003083044A2 (en) * 2002-03-25 2003-10-09 Condros, Inc. Tissue analogs for in vitro testing and method of use therefor
US20050008629A1 (en) * 2002-05-08 2005-01-13 Interpore Orthopaedics, A Delaware Corporation Encapsulated AGF cells
EP1531879A1 (de) * 2002-06-28 2005-05-25 Novartis AG Verwendung von organischen verbindungen
FR2845691B1 (fr) * 2002-10-10 2004-12-10 Centre Nat Rech Scient Nouvelles cellules endotheliales, anticorps diriges contre ces cellules et leur utilisation, notamment pour le criblage de substances inhibant l'angiogenese
US20040156878A1 (en) * 2003-02-11 2004-08-12 Alireza Rezania Implantable medical device seeded with mammalian cells and methods of treatment
WO2004111207A1 (en) * 2003-06-09 2004-12-23 Centelion Multicellular in vitro model of angiogenesis and methods for using the same
US8192348B2 (en) * 2003-07-01 2012-06-05 Regents Of The University Of Minnesota Engineered blood vessels
GB0322789D0 (en) * 2003-09-30 2003-10-29 Lifeforce Group Plc Blood pack for leukocyte banking
WO2005052138A1 (en) * 2003-11-19 2005-06-09 Wisconsin Alumni Research Foundation Cryopreservation of pluripotent stem cells
WO2005072417A2 (en) * 2004-01-27 2005-08-11 The Ohio State University Research Foundation Vascular endothelial growth factors and methods of their use
WO2005108559A2 (en) * 2004-04-23 2005-11-17 Bioe, Inc. Multi-lineage progenitor cells
FR2869533B1 (fr) 2004-05-03 2006-07-28 Sedat Sa Seringue pour interventions medicales et necessaire de reconstitution de substances extemporanees comportant une telle seringue
US7842304B2 (en) 2004-10-29 2010-11-30 Nexeon Medsystems, Inc. Methods and apparatus for treating an injured nerve pathway
WO2006062909A2 (en) * 2004-12-08 2006-06-15 Pervasis Therapeutics, Inc. Methods and compositions for enhancing vascular access
WO2006062871A2 (en) 2004-12-08 2006-06-15 Pervasis Therapeutics, Inc. Materials and methods for minimally-invasive administration of a cell-containing flowable composition
JP5674256B2 (ja) 2004-12-08 2015-02-25 シャイア リジェネラティブ メディシン， インコーポレイテッド 細胞含有流動性組成物の最小侵襲投与のための材料および方法
EP1874919B1 (de) 2005-04-21 2010-06-09 Massachusetts Institute Of Technology Materialien und verfahren zur änderung einer immunreaktion auf exogene und endogene immunogene, einschliesslich genidentischer und nicht-genidentischer zellen, gewebe oder organe
GB0509845D0 (en) 2005-05-13 2005-06-22 Btg Int Ltd Preparation of therapeutic foam
AU2006262682B2 (en) 2005-06-21 2012-07-05 Shire Regenerative Medicine, Inc. Methods and compositions for enhancing vascular access
CN101384704B (zh) 2005-10-12 2012-02-08 细胞生物工程公司 可再吸收的角膜扣状体
WO2007053799A2 (en) * 2005-10-19 2007-05-10 Cd Solutions, Llc Apparatus and method for mixing and transferring medications
CN101437463B (zh) * 2005-11-07 2012-12-05 伯尔拉工业有限公司 通气的安全处理小瓶配接器

Also Published As

Publication number Publication date
CN102743792B (zh) 2014-09-24
EP1901680B1 (de) 2015-04-15
IL188263A0 (en) 2009-02-11
US20130210142A1 (en) 2013-08-15
IL220806A (en) 2014-05-28
EP1901680A2 (de) 2008-03-26
EP2361591A2 (de) 2011-08-31
AU2006262682A1 (en) 2007-01-04
JP5632580B2 (ja) 2014-11-26
CN101257861A (zh) 2008-09-03
AU2006262682B2 (en) 2012-07-05
SG195537A1 (en) 2013-12-30
CA2818182C (en) 2015-04-14
IL188263A (en) 2014-05-28
EP2361591A3 (de) 2011-12-21
US9023377B2 (en) 2015-05-05
CN101878757A (zh) 2010-11-10
WO2007001744B1 (en) 2007-12-21
IL220806A0 (en) 2012-08-30
CN102743792A (zh) 2012-10-24
CN101257861B (zh) 2012-12-05
CA2612751A1 (en) 2007-01-04
WO2007001744A3 (en) 2007-10-04
US20090035346A1 (en) 2009-02-05
JP2012166084A (ja) 2012-09-06
JP2008546406A (ja) 2008-12-25
ES2541684T3 (es) 2015-07-23
CA2818182A1 (en) 2007-01-04
WO2007001744A2 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
IL212764A0 (en) Methods and compositions for enhancing vascular access
SG161258A1 (en) Methods and compositions for enhancing vascular access
Yao et al. Fibrin-based tissue-engineered blood vessels: differential effects of biomaterial and culture parameters on mechanical strength and vascular reactivity
GB2434105A (en) Fibronectin-modified ECM tissue graft constructs and methods for preparation and use thereof
WO2007035843A3 (en) Methods and compositions for organ and tissue functionality
MX2009001323A (es) Aposito solido para tratar tejido herido.
WO2007064881A3 (en) Implantable microbial cellulose materials for various medical applications
DE60018044D1 (de) Neue biomaterialien
EP2420567A3 (de) Verfahren und Zusammensetzungen zur Behandlung von Knochendefekten mit Plazentazellenpopulationen
WO2004101758A3 (en) Composition for maintaining organ and cell viability
KR102269612B1 (ko) 미용적 유방 충전을 위해 또는 안면 충전 및/또는 회생을 위해 체외 확장 지방조직-유래 줄기세포를 이용하는 지방 충전물
WO2004076631A3 (en) Biologically active native biomatrix composition
ATE508758T1 (de) Nicht-abbaubare wenig quellende wasserlösliche röntgendichte hydrogels
WO2006093857A3 (en) Method of providing readily available cellular material derived from peripheral blood and a composition thereof
WO2006062909A3 (en) Methods and compositions for enhancing vascular access
AU2003257319A1 (en) Biocompatible porous ti-ni material
MX2010006650A (es) Materiales y metodos para el tratamiento de proliferacion vascular ocular patologica.
RU2539918C1 (ru) Способ получения тканеспецифического матрикса для тканевой инженерии паренхиматозного органа
ATE411057T1 (de) Injizierbare implantate auf keramikbasis zur füllung von weichgewebe
WO2003099230A3 (en) Electroprocessed collagen and tissue engineering
EP2198895A8 (de) Poröse Strukturen einer von Mikroben abgeleiten Cellulose zur Einpflanzung in vivo
CN208447853U (zh) 一种隆鼻手术用的鼻假体
Sharma et al. Albumin removal from human fibrinogen preparations for manufacturing human fibrin-based biomaterials
WO2005058243A3 (en) Methods for treating cancer using vascular endothelial cell growth inhibitor vegi-192a
BR112023018291A2 (pt) Implante de reconstrução mamária